Meeting
2016 Gastrointestinal Cancers Symposium
Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after neoadjuvant chemoradiation therapy.
Authors
Chang-gon Kim
Yonsei Cancer Center, Seoul, South Korea
Chang-gon Kim , Minkyu Jung , Inkyung Jung , Sang Joon Shin , Seung Hoon Beom , Joo Hoon Kim , Su Jin Heo , Ji Hyung Kim , Woong Sub Koom , Hyuk Hur , Byung Soh Min , Nam Kyu Kim , Ho Geun Kim , Joong Bae Ahn
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Cancers of the Colon, Rectum, and Anus
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 760)
DOI
10.1200/jco.2016.34.4_suppl.760
Abstract #
760
Poster Bd #
N13
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Total neoadjuvant treatment versus standard chemoradiation to increase the sphincter preservation rate for distal locally advanced rectal cancer (TESS).
First Author: Weiwei Xiao
Poster
2021 ASCO Annual Meeting
Long-term outcome of a phase III trial on neoadjuvant chemoradiation with capecitabine and irinotecan in patients with locally advanced rectal cancer: Updated results of the CinClare trial.
First Author: Ji Zhu
Poster
2018 Gastrointestinal Cancers Symposium
The impact of chronic kidney disease in locally advanced rectal cancer patients treated with neoadjuvant chemoradiation.
First Author: Shaan Dudani
Poster
2018 Gastrointestinal Cancers Symposium
Postoperative chemotherapy in patients who are pN+ following neoadjuvant chemoradiation for locally advanced esophageal cancer.
First Author: Samual Francis